JOHNSON & JOHNSON (JNJ)
Pharmaceutical Preparations · Pharmaceutical Preparations · NYSE
$275.21
+1.48%
Investru Score
64.7 / 100
Good
Why is JNJ moving?
JNJ is up 1.48% today, in line with its broader uptrend.
Business overview
AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.
Bull case
AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.
Bear case
AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.
Want the complete AI research memo? Unlock full stock analysis →
Score breakdown
- Financial Quality
- 74
- Growth
- 50
- Profitability
- 68
- Balance Sheet
- 46
- Valuation
- 64
- Momentum
- 96
Financial quality
AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.
- ROIC
- 22.2%
- ROE
- 32.9%
- FCF Margin
- 20.9%
- Free Cash Flow (TTM)
- $19.7B
- Earnings Quality (OCF ÷ Net Income)
- 0.9x
Valuation
AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.
- P/E (TTM)
- Data unavailable
- Forward P/E
- Data unavailable
- PEG (P/E ÷ EPS Growth)
- Data unavailable
- Company Median PEG
- Data unavailable
- Price / Sales
- 0.0x
- EV / EBITDA
- Data unavailable
- FCF Yield
- Data unavailable
Key risks
- AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.(Probability: Medium · Impact: Medium)
Latest earnings
- Q2 FY26 EPS
- $2.27
- Estimate
- Data unavailable
- Surprise
- Data unavailable
AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.
SEC filings
- 10-Q · Q2 FY26 · period ended 2026-06-28Filed 2026-07-23
- 10-Q · Q1 FY26 · period ended 2026-03-29Filed 2026-04-22
- 10-K · FY25 · period ended 2025-12-28Filed 2026-02-11
- 10-Q · Q3 FY25 · period ended 2025-09-28Filed 2025-10-22
- 10-Q · Q2 FY25 · period ended 2025-06-29Filed 2025-07-24
- 10-K · FY24 · period ended 2024-12-29Filed 2025-02-13
- 10-K · FY23 · period ended 2023-12-31Filed 2024-02-16
- 10-K · FY22 · period ended 2023-01-01Filed 2023-02-16
- 10-K · FY21 · period ended 2022-01-02Filed 2022-02-17
Event filings (8-K) aren't covered by this page's data source yet — only 10-K/10-Q are shown above.
Market cap $0 · 52-week range $173.33–$281.07 · market data as of Sep 2, 2026, 4:00 PM ET · latest SEC filing: 2014-10-30
Related stocks
Get the full interactive report
Technicals, earnings history, news, bull/base/bear scenarios, Ask the Stock, and more — free to start.
Analyze JNJ with Investru AINot investment advice. Investru AI summarizes public data and AI-generated analysis for informational purposes only.